Literature DB >> 30181007

Comparison between the Staphylococci aureus and coagulase-negative staphylococci infected total joint arthroplasty treated by two-stage revision: A retrospective study with two year minimum follow-up.

Zhisen Gao1, Yinqiao Du1, Shang Piao1, Jingyang Sun1, Xiang Li1, Yonggang Zhou2.   

Abstract

BACKGROUND: Staphylococcus species are major pathogens of peri-prosthetic joint infection (PJI). Coagulase-positive staphylococci and coagulase-negative staphylococci have different intrinsic virulences. However, few studies have specifically compared the clinical manifestations and two-stage revision outcomes of PJI caused by these two species.
METHODS: We retrospectively collected 260 arthroplasty patients who underwent a two-stage revision because of PJI from January 2003 to June 2015 in our institute because of PJI. Sixty-four patients (36 hips and 28 knees) and 23 patients (13 hips and 10 knees) were infected by coagulase-negative staphylococci (CoNS) and SA, respectively.
RESULTS: The preoperative mean ESR value of the SA group was higher than that of the CoNS group (median, 60.9 VS 35.9; P < 0.001). Seventeen (73.9%) of the 23 SA infected patients had a sinus tract, while only 12 (18.8%) of the 64 CoNS-infected patients had this symptom (73.9% VS 18.8%; P < 0.001). At the time of follow-up, 58 (90.6%) of the 64 CoNS-infected patients had successfully controlled the infection. In the SA group, 20 (87.0%) patients ultimately acquired successful control (90.6% VS 87.0%; P = 0.923). Surgical history was identified as a potential risk factor (OR = 6.2, 95%CI 1.17-32.4) for prognosis when potential covariates were adjusted.
CONCLUSIONS: SA infection has a higher ESR value and a more frequent occurrence of sinus tract. The infection control rate of the two-stage revision protocol was close to 90% for both SA and CoNS species, and there is no statistically significant difference in the eradication rate of infection between the SA and CoNS groups. Surgical history may be a good predictor of failure for PJI patients treated with two-stage revision.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30181007     DOI: 10.1016/j.jos.2018.04.017

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  4 in total

1.  The reasons for and mortality of patients unable to receive reimplantation after resection arthroplasty for chronic hip periprosthetic infection.

Authors:  Yu-Hsuan Lin; Chao-Jui Chang; Chih-Wei Chang; Yi-Chen Chen; Ta-Wei Tai
Journal:  Int Orthop       Date:  2021-11-08       Impact factor: 3.075

2.  The species distribution, antimicrobial resistance and risk factors for poor outcome of coagulase-negative staphylococci bacteraemia in China.

Authors:  Jiewei Cui; Zhixin Liang; Zhenfei Mo; Jianpeng Zhang
Journal:  Antimicrob Resist Infect Control       Date:  2019-04-24       Impact factor: 4.887

3.  What is the most cost-effective strategy for nasal screening and Staphylococcus aureus decolonization in patients undergoing total hip arthroplasty?

Authors:  Hisahiro Tonotsuka; Hajime Sugiyama; Ayano Amagami; Keigo Yonemoto; Ryuichi Sato; Mitsuru Saito
Journal:  BMC Musculoskelet Disord       Date:  2021-02-01       Impact factor: 2.362

4.  Significant Difference in Antimicrobial Resistance of Bacteria in Septic Revision between Total Knee Arthroplasty and Total Hip Arthroplasty.

Authors:  Stella Stevoska; Felix Himmelbauer; Julian Stiftinger; Christian Stadler; Lorenz Pisecky; Tobias Gotterbarm; Antonio Klasan
Journal:  Antibiotics (Basel)       Date:  2022-02-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.